Certified Clinical Research Associate (CCRA) Practice Exam 2026 – Complete Preparation Guide

The requirement for sponsors to obtain financial disclosures from investigators for one year following the completion of the trial is rooted in compliance with regulatory guidelines and ethical standards in research. This duration allows for adequate oversight of any potential financial conflicts of interest that could influence the conduct of the study or the reporting of results. By maintaining this practice for a year post-trial, sponsors can ensure that any financial relationships that could impact the integrity of the research are monitored, helping to uphold the ethical standards of scientific inquiry and protect the interests of participants and the integrity of the research community.

The other choices do not align with established regulatory frameworks. Keeping disclosures for the duration of the trial does not provide post-trial awareness of potential conflicts, while requiring them for the lifetime of the investigator would be impractical and unnecessary. Relying on financial disclosures only until the study is published might not cover situations where post-publication financial interests arise, hence lacking sufficient oversight.